PRESS RELEASE: #108/2020

DATE: September 8, 2020

The national anti-drug campaign got a big boost with the collaborative efforts of the Philippine Drug Enforcement Agency (PDEA), Dangerous Drugs Board (DDB), and Food and Drug Administration (FDA) to regulate and monitor the sale and dispensing of controlled and addictive drugs and substances.

During the signing on Tuesday, September 8, 2020, of a Memorandum of Agreement (MOA) among the three agencies at the PDEA National Headquarters in Quezon City, the heads of the PDEA, DDB, and FDA said their joint efforts are critical components of the top priority program of President Rodrigo Duterte in the eradication of the illegal drug problem.

The signatories were PDEA Director General Wilkins M. Villanueva, Secretary Catalino S. Cuy, Chairperson of DDB, and Undersecretary Rolando Enrique Domingo, Director General of FDA.

“The MOA aims to strengthen our mandates to take action on President Duterte’s marching order to free the country from illegal drugs,” said Villanueva.

“This Memorandum of Agreement among PDEA, DDB and FDA is timely because  our  respective  agencies  play a  crucial role  in  the  efficient  and effective

implementation of the National Drug Control Strategy formulated by the Dangerous Drugs Board supports the standards and regulations adopted by the Food and Drug Administration, and strengthens PDEA’s enforcement, control and prevention of the proliferation of regulated drugs,” the PDEA chief explained.

Under the agreement’s salient provisions, the parties will focus on:

  1. Providing resource speakers for the anti-illegal drug programs, policies, advocacies, information drive, and other related activities;
  1. Updating of the list of dangerous drugs and controlled precursors and essential chemicals to ensure that each parties’ record corresponds as documentary requirements in processing registration of licenses; and
  1. Assist one another in the conduct of an investigation, intelligence gathering, seizure operations of health products containing dangerous drugs, and in the prosecution of cases.

                                                         # # #